Triple therapy with salmeterol/fluticasone propionate 50/250 plus tiotropium bromide improve lung function versus individual treatments in moderate-to-severe Japanese COPD patients: a randomized controlled trial - Evaluation of Airway sGaw after treatment with tripLE. [electronic resource]
Producer: 20160920Description: 2393-404 p. digitalISSN:- 1178-2005
- Administration, Inhalation
- Adrenergic beta-2 Receptor Agonists -- administration & dosage
- Aged
- Area Under Curve
- Bronchodilator Agents -- administration & dosage
- Cholinergic Antagonists -- administration & dosage
- Cross-Over Studies
- Double-Blind Method
- Drug Administration Schedule
- Female
- Fluticasone-Salmeterol Drug Combination -- administration & dosage
- Forced Expiratory Volume
- Humans
- Japan
- Lung -- drug effects
- Male
- Middle Aged
- Nebulizers and Vaporizers
- Plethysmography
- Predictive Value of Tests
- Pulmonary Disease, Chronic Obstructive -- diagnosis
- ROC Curve
- Recovery of Function
- Severity of Illness Index
- Spirometry
- Time Factors
- Tiotropium Bromide -- administration & dosage
- Treatment Outcome
- Vital Capacity
No physical items for this record
Publication Type: Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.